Evid Invest
Holders — by stockHoldings — by fund

Checkpoint Capital L.P.

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001977548

$442.3M

disclosed book value

8

positions

39.3%

largest position share

Positions, as of 2026-09-30

top 8 of 8 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1ARGXARGENX SE181,500$174.0M39.3%
2RYTMRHYTHM PHARMACEUTICALS INC1.2M$115.8M26.2%
3RVMDREVOLUTION MEDICINES INC422,911$86.8M19.6%
4CYTKCYTOKINETICS INC517,278$34.1M7.7%
5IRONDISC MEDICINE INC399,830$26.2M5.9%
6SEPNSEPTERNA INC64,000$2.5M0.6%
7TRVITREVI THERAPEUTICS INC137,000$2.0M0.4%
8OCSOCULIS HOLDING AG99,500$929,3300.2%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.